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Introduction. It is estimated that over 15% of couples of reproductive age face infertility 
worldwide. In about half of these cases the male factor is involved. To assess the potential of 
male fertility the spermiogram analysis may not always be an optimal diagnostic tool, but 
it remains the basic clinical tool.
Material and methods. The purpose of the study is to analyze the regional tendencies 
of the semen quality in male partners of couples facing infertility. A retrospective study 
of 4625 patients subject to semen analysis between 2012-2018 was conducted. All semen 
samples were collected after a recommended period of sexual abstinence of three to five 
days. The spermiogram analysis was performed by the computerized method according to 
WHO guidelines for Human Semen analysis, 2010.
Results. Of the total number of 4625 men examined, 1861 (40.2%) presented normal values 
of semen – normozoospermia, and 2764 (59.8%) showed abnormal semen parameters. 
Asthenozoospermia was the most common abnormality profile recorded in 1394 (30.2%) 
men, followed by oligoasthenozoospermia diagnosed in 973 men (21.0%). Azoospermia 
was found in 200 men with an estimated prevalence of 4.3%. In 113 men examined, 
oligozoospermia was found in 2.4%. Oligoasthenoteratozoospermia was diagnosed in 1.5% 
and necrozoospermia in 0.3%.
Conclusion. The study provides the first evidence that semen quality in men in the Republic 




diagnostic, valori de 
referință.
EVOLUȚIA CALITĂȚII MATERIALULUI SEMINAL LA BĂRBAȚII PARTENERI DIN 
CUPLURILE INFERTILE ÎN REPUBLICA MOLDOVA
Introducere. La nivel mondial se estimează că peste 15% dintre cuplurile de vârstă 
reproductivă se confruntă cu infertilitatea, iar în aproximativ jumătate din aceste cazuri 
este implicat factorul masculin. Pentru evaluarea potențialului de fertilitate masculină 
spermograma poate să nu fie întotdeauna un instrument de diagnostic optim, cu toate 
acestea însă rămâne în continuare instrumentul clinic de bază.
Material și metode. Scopul: analiza tendințelor regionale ale calității materialului seminal 
la bărbații din cadrul cuplurilor ce se confruntă cu infertilitatea. Studiu retrospectiv a fost 
efectuat în perioada 2012-2018 pe un eșantion de 4625 bărbați care au făcut analize ale 
materialului seminal. Recoltarea probelor a fost făcută după abstinență de la ejaculare timp 
de 3-5 zile în condiții de laborator. Spermograma s-a realizat prin metoda computerizată 
conform criteriilor și valorilor de referință stabilite de OMS în anul 2010. 
Rezultate. Din numărul total de 4625 de bărbați investigați, 1861 (40,2%) au prezentat 
valori normale ale materialului seminal normozoospermie și 2764 (59,8%) au prezentat 
tulburări de spermatogeneză. Cea mai frecventă anomalie a spermatogenezei a fost 
înregistrată astenozoospermia – la 1394 de bărbați cu o frecvență de 30,2%, urmată de 
oligoastenozoospermia – la 973 de bărbați în 21,0% din cazuri. La 200 de bărbați a fost 
înregistrată azoospermia, frecvența fiind de 4,3%, iar la 113 bărbați investigați a fost 
depistată oligozoospermia cu frecvența de 2,4%, oligoastenoteratozoospermia – în 1,5% și 
necrozoospermia – în 0,3%.
Concluzii. Studiul confirmă, că calitatea materialului seminal a bărbaților din Republica 
Moldova, care se confruntă cu infertilitatea în cuplu, se deteriorează de-a lungul anilor. 
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INTRODUCTIONInfertility affects an estimated rate of 15% of cou-ples of reproductive age worldwide, and in about half of these cases the male factor is involved (1).The causes of infertility can be divided into four broad categories: 1) female factor; 2) male fac-tor; 3) couple factor – due to cumulative female and male infertility; 4) idiopathic infertility, une-xplained. The exact percentage for each of these 
categories is difficult to determine; however, it is generally reported that in about 40% of cases infertility is due to female cause, in 40% – male cause, and in 20% – anomalies detected in both partners (1, 2). Thus, the examination of the male partner is as important as the female one for the assessment of couple’s fertility. Medical history and physical examination are standard assess-ments for all men, including semen analysis.The spermiogram evaluation is relevant for the appreciation of the functional status of the semi-niferous tubules, epididymis, and accessory sex glands. The prognostic value of semen characte-ristics, such as sperm concentration, percentage of 
motility, and morphology represents the first line of examination in the diagnosis of male infertility (3). Semen analysis may not always be an optimal diagnostic tool, but it still remains the basic clinical tool for the evaluation of male fertility potential (4).Important treatment decisions in male infertility are largely based on spermiogram results. There-
fore, it is essential that the human semen analysis be performed according to the updated require-ments of the World Health Organization (WHO), 2010 (5). In recent years, the European Society for Human Reproduction and Embryo-logy (ESHRE), in collaboration with the WHO, have developed a program to improve laboratory standardization in terms of sperm sample diagnosis and assessment criteria (6).
MATERIAL AND METHODS
The purpose of the study is to analyze the regional tendencies of semen quality in male partners of couples facing infertility.The study presents a retrospective evaluation of 4 625 patients in the Republic of Moldova subject to semen analysis during 2012-2018. All semen samples were collected in laboratory conditions after a recommended period of sexual abstinence 
of three to five days. Each sample was incubated at 37oC and analyzed within an hour. The spermi-ogram analysis was performed by the computeri-zed method on the automated analyzer SQA IIC-P (Medical Electronic Systems, USA). Semen analy-sis was performed according to the WHO Labora-tory Manual for the Examination and Processing of Human Semen, 5th edition, 2010 (tab. 1). All patients are part of infertile couples who made appointments for doctor`s consultation in the Re-promed Center.
Table 1. Semen parameters and reference values according to WHO (2010).
Abstinence (days) 3-7 daysVolume (mL) ≥ 1.5 mLColor ≤2 cm Liquefaction time ≤60 minViscosity 2 cmpH ≥7.2Leukocytes ≤ 1 mln/mLSperm Concentration (mln/mL) ≥ 1.5 mLTotal number of spermatozoa (mln/ejaculate) ≥ 39 mlnProgressives sperm motility (%) ≥ 32 %Concentration of motile spermatozoa (mln/mL) ≥ 10 mln/mLTotal number of motile spermatozoa (mln/ejaculate) ≥ 15 mlnConcentration of functional spermatozoa (mln/mL) ≥ 7 mln/mLTotal number of functional spermatozoa (mln/ejaculate) ≥ 10.5 mln/mLMotility index ≥ 80Morphology (Normal forms) (%) ≥4%Vitality (9%) ≥ 58
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Interpreting the results, the spermiogram diagno-sis was made according to the descriptive termi-nology of the same WHO guidelines as follows:– normozoospermia: total number/percentage of sperm with progressive mobility and normal morphology, being of equal value or above the reference values;– oligozoospermia: total number of sperm/sperm concentration below lower reference limit;– asthenozoospermia: sperm motility below 40% or rapid progressive sperm motility <32%;– teratozoospermia: percentage of normal sperm below 4%;– oligoasthenozoospermia: low concentration and low percentage of progressively motile sperm;– oligoteratozoospermia: low total number of sperm and low percentage of normal forms;– asthenoteratozoospermia: percentage of moti-le sperm and normal sperm below low referen-ce limit;– oligoasthenoteratozoospermia: low total num-ber of sperm/low percentage of motile sperm and normal forms;– cryptozoospermia: very low spermatozoa con-
centration in ejaculate ≤1 million/mL;– hypospermia: semen volume < 1,5 mL;
– hyperspermia: semen volume >1,5 mL;– leukospermia/pyospermia: presence of leu-kocytes in ejaculate above reference limit;– hematospermia: presence of blood in ejaculate;– necrozoospermia: low percentage of live and high percentage of immotile sperm;– aspermia: complete lack of semen with ejaculation;– azoospermia: absence of spermatozoa in the sediment of a centrifuged semen sample.
RESULTS In the biology laboratory of the Repromed Center, Chisinau, Republic of Moldova, the spermiogram was performed in 4625 men, during 2012-2018. The Repromed Center is an Assisted Reproduction Center where the vast majority of infertility cou-ples from all over the country present themselves. Spermiograms were performed over the following years: 2012 – 206 patients, 2013 – 702 patients, 2014 – 854 patients, 2015 – 800 patients, 2016 – 717 patients, 2017 – 703 patients, and 2018 – 643 patients. The number of semen analyses in the studied period is relatively constant. Except for 2012, because patients were registered since the middle part of the year since the Repromed Center started activity (tab. 2).
Table 2. Distribution of men according to their semen characteristics in the period 2012-2018  in the Republic of Moldova.
Semen parameters Absolute number %2012 2013 2014 2015 2016 2017 2018 Total
Normozoospermia 103 358 348 340 260 235 217 1 861 40.2
Oligozoospermia 13 24 26 16 18 10 6 113 2.4
Oligoasthenozoospermia 27 90 166 173 165 170 182 973 21.0
Asthenozoospermia 44 179 245 231 235 250 210 1 394 30.2
Oligoasthenoteratozoospermia 5 13 11 12 11 13 3 68 1.5
Necrozoospermia 6 6 3 1 16 0.3
Azoospermia 14 32 52 28 25 25 24 200 4.3
Total 206 702 854 800 717 703 643 4 625 100
Of the total number of 4 625 men examined, 1 861 (40.2%) presented normal values of semen – nor-mozoospermia, 2 764 (59.8%) showed abnormal 
semen parameters. The most common profile of abnormality recorded in our study was astheno-zoospermia in 1 394 men from 2012 to 2018 with a frequency of 30.2%, followed by oligoastheno-zoospermia being diagnosed in 973 men – 21.0%. Azoospermia was recorded in 200 men with an estimated prevalence of 4.3%. In 113 men exami-ned, the frequency of oligozoospermia accounted 
for 2.4%. In 113 men examined, oligozoospermia was detected in 2.4%. Oligoasthenoteratozoos-permia was diagnosed in 68 men (1.5%) and ne-
croszoospermia in 16 men (0.3%) (tab. 2, fig. 1).Normozoospermia was considered according to the following WHO criteria: sperm concentrati-
on ≥1.5 mln/mL, total number of sperm cells ≥39 
mln, progressive sperm motility ≥32% and mor-
phology ≥4%. The results of normozoospermia analysis were recorded in 2012 and 2013 with a 
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frequency of 50.9%. In 2014, the normal values of spermiogram decreased by 10.2%, the frequency accounted for 40.7%. In 2015 the situation im-
proved insignificantly compared to 2014 by 1.8%. 
Over the following years a decrease of normal values of spermatogenesis was also observed. In 2016 the frequency accounted for 36.3%, in 2017 
– 33.4%, in 2018 – 33.7% (fig. 2).
Figure 1. Distribution of patients according to semen analysis during the period 2012-2018.
Figure 2. Frequency of normozoospermia in men during 2012-2018.According to the results of asthenozoospermia analysis in 2012 the frequency was 21.7%. In 2013 the frequency increased by 3.7% compared to the previous year. Over the following years the 
values of asthenozoospermia also increased, in 2014 – 28.6%, in 2015 – 28.8%, in 2016 – 32.7%, 
in 2017 – 35.5%, and in 2018 – 32.6% (fig. 3).
Figure 3. Frequency of men with asthenozoospermia during 2012-2018.
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DISCUSSIONSThe study shows that during 2012-2018, the ab-normal semen quality was found in approximately 59.8% of male partners of couples facing infer-tility (tab. 2). A high incidence of spermatogenic disorders is also found in other studies (7, 8, 9) According to our data, this percentage increased from 50% in 2012 to 66.3% in 2018 (tab. 2).
This represents a significant increase in sperma-togenesis abnormalities, although the WHO in-troduced lower baseline values in 2010. Thus, an alarming phenomenon of decreased male fertility can be observed in fertility clinics in the Republic of Moldova, which could be correlated with sperm decline described in the literature. This has been illustrated by several studies from multiple world regions that argue that men’s reproductive heal-th has been in rapid decline in the recent years (10, 11).In the present study we observe that sperm con-centration in the semen and healthy sperm count have decreased considerably. If in 2012 and 2013 the frequency of normozoospermia was 50.9%, over the following years a decrease in the normal values of spermatogenesis could be observed, ac-
counting for 33.7% in 2018 (fig. 2).
The most common profile of abnormality in our study was asthenozoospermia recorded in 1394 
men with a frequency of 30.2% (fig. 1). It is very noticeable that the abnormal frequency of sperm motility increased from 2012 to 2018. Thus, in 2012 the frequency of asthenozoospermia was 21.7%, in 2014 – 28.6% it increased, in 2015 – 28.8%, 2016 –32.7%, in 2017 – 35.5%. In 2018 there was a slight decrease of asthenozoospermia – 32.6%, most probably due to a lower number of appointments of couples with infertility compared 
to the previous year (fig. 3). According to literatu-re data, this abnormality is found in 40% of men, 
affecting their fertility. The role of socio-psyc-ho-behavioral factors in the development of this abnormality has been demonstrated. Psychologi-
cal stress, smoking and alcohol are modifiable risk factors for the number of motile sperm (12). Also, 
sperm motility depends on its specific structures 
such as microtubules, outer dense fibers and mi-tochondria that provide energy for sperm move-ments (13).The second cause of spermatogenesis disorder 
identified in our study was oligoastenozoosper-mia with a frequency of 21.0%. Oligoastenozoos-permia is a combination of reduced sperm motility and low sperm count. According to bibliographic sources it is the most common cause of male infer-tility (14). The causes of this disorder are hetero-geneous, such as cryptorhidia, varicocele, chronic infections, hormonal causes, psychoemotional cau-ses, metabolic causes, etc. In 20% its etiology and pathogenesis are not fully elucidated and may be 
associated with specific gene abnormalities (13).The frequency of azoospermia in the current study accounts for 4.3%. According to bibliographic so-urces azoospermia is found in 8% of infertile men and in 1% of the male population (15). In the case of lack of sperm or an extremely small number, a 
genetic cause may be identified in about 21-29% (16). In this context, cytogenetic tests for karyoty-pe analysis as well as molecular genetic evaluati-on of Y-chromosome microdeletions analysis and mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene are fully jus-
tified and important to exclude a possible cause of genetic origin. Abnormal genotype may be present in up to 12% of azoospermic men and 4% of oli-
gospermic men. Cystic fibrosis screening is recom-mended for azoospermia if it is due to congenital bilateral absence of the vas deferens (CBAVD). Optional Y-chromosome microdeletion screening can be carried out if sperm count is <5 million/mL.
CONCLUSION1. Our results clearly show that semen quality in the population of men in couples with infertility in the Republic of Moldova decreased from 2012 to 2018. As many authors suggest, we also believe that environmental and lifestyle factors have negatively affected the quality of semen development. The con-tribution of genetic factors cannot be excluded either. 2. Therefore, the analysis of the regional tendencies of semen quality is necessary and can be considered an indirect factor in assessing the tendencies in male infertility.
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